Israel Life Sciences: Funding Gaps and Growth

Israel has a thriving bio-science environment, reflected in high patents per capita and biomedical discoveries that are the foundation of global blockbuster drugs.  However, the local industry, largely based upon these scientific innovations, suffers from not realizing its economic and technology potential.

This research investigates capital structure limitations and related obstacles faced by life science start-ups in Israel, and suggests innovative financial models to overcome these gaps and allow the industry to reach its potential.

Netta Linzen
As a fellow, Netta interned in the Economics and Strategy Unit, at the Chief Scientist's Office in the Ministry of Economy. Her research focused on identifying and assessing potential financial and business models to accelerate the commercialization of heath technology IP. Prior...
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.